ANTGX
Price
$11.10
Change
-$0.00 (-0.00%)
Updated
Jun 2 closing price
Net Assets
551.01M
TRWTX
Price
$28.36
Change
+$0.17 (+0.60%)
Updated
Jun 2 closing price
Net Assets
4.32B
Interact to see
Advertisement

ANTGX vs TRWTX

Header iconANTGX vs TRWTX Comparison
Open Charts ANTGX vs TRWTXBanner chart's image
ANTGX vs TRWTX Comparison Chart in %
View a ticker or compare two or three
VS
ANTGX vs. TRWTX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANTGX is a Hold and TRWTX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TRWTX has more cash in the bank: 4.32B vs. ANTGX (551M). ANTGX pays higher dividends than TRWTX: ANTGX (4.60) vs TRWTX (3.44). ANTGX was incepted earlier than TRWTX: ANTGX (7 years) vs TRWTX (33 years). ANTGX (0.83) is less costly to investors than TRWTX (0.76). ANTGX is a more actively managed with annual turnover of: 71.00 vs. TRWTX (13.00). ANTGX (0) and TRWTX (0) have matching initial minimum investment requirements. TRWTX annual gain was more profitable for investors over the last year : 20.68 vs. ANTGX (18.40). TRWTX return over 5 years is better than : 46.23 vs. ANTGX (25.04).
ANTGXTRWTXANTGX / TRWTX
Total Expense Ratio0.030.764%
Annual Report Gross Expense Ratio0.830.76109%
Fund Existence7 years33 years-
Gain YTD7.87211.99866%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets551M4.32B13%
Annual Yield % from dividends4.603.44134%
Returns for 1 year18.4020.6889%
Returns for 3 years28.4957.3750%
Returns for 5 years25.0446.2354%
Returns for 10 yearsN/A104.63-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATEX66.961.60
+2.45%
Anterix
FRAF56.63-0.39
-0.68%
Franklin Financial Services Corp
MNST88.24-0.86
-0.97%
Monster Beverage Corp
TFX125.24-2.33
-1.83%
Teleflex
VTGN0.58-0.07
-10.42%
VistaGen Therapeutics